FOXO1 and type 2 diabetes mellitus: DPP4i vildagliptin reduces hippocampal FOXO1 and TNF-α levels in AD-PreDM mice [225] and decreases MDA levels, preventing lipid peroxidation, in AD-T2D mice [228].